SymBiosis LLC
North America, District of Columbia, United States, Washington
Description
SymBiosis LLC is a biotech-focused investment vehicle.
Investor Profile
SymBiosis LLC has backed more than 15 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 40% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Life Science, Medical.
Stage Focus
- Series B (53%)
- Series C (13%)
- Series D (13%)
- Convertible Note (7%)
- Post Ipo Equity (7%)
- Series A (7%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Life Science
- Medical
- Therapeutics
- Health Care
- Genetics
- Oncology
- Pharmaceutical
- Biopharma
- Business Development
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does SymBiosis LLC frequently co-invest with?
Which angels does SymBiosis LLC often collaborate with?
What are some of recent deals done by SymBiosis LLC?
Find More Investors Like SymBiosis LLC
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










